Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin in Hypersomnia Syndromes
NCT04026958Phase 2Completed
- Sponsor
- Emory University
- Start
- Sep 2019
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clarithromycin in narcolepsy, idiopathic hypersomnia (IH), sponsored by Emory University. Started Sep 2019; status: completed.
02
Drugs
clarithromycin
03
Conditions
narcolepsyidiopathic hypersomnia (IH)
Beyond the preview
Go deeper on NCT04026958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026958.